Considering m-Ino’s association with oncogenic PI3K pathways and as a proposed cancer inhibitor in human lung cancer48, our m-Ino results may indicate its function as an Hb tissue defense response in cancerous prostates, one providing endogenous tumor suppression of aggressive prostate cancer growth. Here, GSTM1 is linked to Familial prostate cancer.